©The Author(s) 2020.
World J Gastrointest Pharmacol Ther. Nov 8, 2020; 11(5): 110-122
Published online Nov 8, 2020. doi: 10.4292/wjgpt.v11.i5.110
Published online Nov 8, 2020. doi: 10.4292/wjgpt.v11.i5.110
Table 1 Indication and contraindication for liver resection for liver metastases originated from gastric cancer.
| Indicated | Contraindicated |
| Radical resection of the primary GC | Tumor number of > 5 |
| No tumor in the remnant liver (curability of LR) | Peritoneal dissemination (incurability of LR) |
| Remnant liver volume of > 40% | Extrahepatic unresectable site (incurability of LR) |
| Tumor number of ≤ 5 | |
| Any tumor size | |
| No unresectable site (curability of LR) | |
| Regardless of unilobular or bilobular LMGC | |
| Regardless of cytology (CY0 or CY1) | |
| Regardless of synchronous or metachronous LMGC |
- Citation: Yazawa T, Hori T, Yamamoto H, Harada H, Yamamoto M, Yamada M, Tani M, Sato A, Kamada Y, Tani R, Aoyama R, Sasaki Y, Zaima M. Do liver metastases from gastric cancer contraindicate aggressive surgical resection? A 14-year single-center experience. World J Gastrointest Pharmacol Ther 2020; 11(5): 110-122
- URL: https://www.wjgnet.com/2150-5349/full/v11/i5/110.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v11.i5.110